Department of Psychiatry, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
The State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong SAR, China.
BMC Psychiatry. 2022 Oct 13;22(1):641. doi: 10.1186/s12888-022-04288-1.
This study aimed to investigate the changes in perceived public stigma (PPS) towards psychosis, and endorsement of medication treatment between 2009 to 2018 in the Hong Kong Chinese population.The role of education level on the changes in PPS and endorsement of medication treatment for psychosis was also examined.
Telephone survey of the general population was conducted in 2009, 2014, and 2018. PPS was assessed using the revised Link's Perceived Discrimination-Devaluation Scale. Endorsement of medication was measured using an item asking if individuals with psychosis requires medication to manage their symptoms. Education level was separated into three categories (primary, secondary, and tertiary) for analysis. Factorial analysis of covariance was used to examine the main effects of survey year, education and endorsement of medication on stigma, and the interaction between survey year and education level, and survey year and endorsement of medication on PPS.
1016, 1018, and 1514 respondents completed the surveys in 2009, 2014, and 2018, respectively. PPS was found to be stable across the three public surveys. Endorsement of medication treatment was associated with higher PPS. An interaction effect between survey year and education level onPPS was observed. PPS was significantly lower and fewer respondents endorsed medication treatment in 2018 in the tertiary education group than in previous years.
Current findings suggest that a targeted approach may be required for different education groups when developing anti-stigma public campaigns. Inclusion of other aspects of knowledge about psychosis may also be useful in reduction of PPS.
本研究旨在调查香港华人对精神疾病的感知公众污名（PPS）和药物治疗态度在 2009 年至 2018 年期间的变化。本研究还探讨了教育程度对 PPS 和对精神疾病药物治疗态度变化的影响。
在 2009 年、2014 年和 2018 年，对一般人群进行了电话调查。使用修正后的 Link 感知歧视-评价量表评估 PPS。通过询问是否需要药物治疗来控制精神疾病患者的症状来衡量对药物治疗的认可程度。将教育程度分为三个类别（小学、中学和大学）进行分析。采用协方差因子分析检验调查年份、教育程度和药物治疗对污名的主要影响，以及调查年份与教育程度、调查年份与药物治疗对 PPS 的交互作用。
分别有 1016、1018 和 1514 名受访者在 2009、2014 和 2018 年完成了调查。在这三次公众调查中，PPS 均保持稳定。对药物治疗的认可与更高的 PPS 相关。在 PPS 上观察到调查年份与教育程度之间的交互作用。在大学教育组中，与前几年相比，2018 年 PPS 明显更低，且更多的受访者反对药物治疗。
目前的研究结果表明，在制定反污名公众宣传活动时，可能需要针对不同的教育群体采取有针对性的方法。纳入有关精神疾病的其他方面的知识也可能有助于减少 PPS。
